177 related articles for article (PubMed ID: 22996314)
21. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.
Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C
Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868
[TBL] [Abstract][Full Text] [Related]
22. Three-dimensional magnetic resonance observation of cartilage repair tissue (MOCART) score assessed with an isotropic three-dimensional true fast imaging with steady-state precession sequence at 3.0 Tesla.
Welsch GH; Zak L; Mamisch TC; Resinger C; Marlovits S; Trattnig S
Invest Radiol; 2009 Sep; 44(9):603-12. PubMed ID: 19692843
[TBL] [Abstract][Full Text] [Related]
23. Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues.
Tamada T; Sone T; Toshimitsu S; Imai S; Jo Y; Yoshida K; Yamamoto A; Yamashita T; Egashira N; Nagai K; Fukunaga M
J Magn Reson Imaging; 2008 Mar; 27(3):552-6. PubMed ID: 18219616
[TBL] [Abstract][Full Text] [Related]
24. Pediatric abdominal masses: diagnostic accuracy of diffusion weighted MRI.
Kocaoglu M; Bulakbasi N; Sanal HT; Kismet E; Caliskan B; Akgun V; Tayfun C
Magn Reson Imaging; 2010 Jun; 28(5):629-36. PubMed ID: 20378294
[TBL] [Abstract][Full Text] [Related]
25. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
Song I; Kim CK; Park BK; Park W
AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
[TBL] [Abstract][Full Text] [Related]
26. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.
Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286
[TBL] [Abstract][Full Text] [Related]
27. Comparison of different mathematical models of diffusion-weighted prostate MR imaging.
Quentin M; Blondin D; Klasen J; Lanzman RS; Miese FR; Arsov C; Albers P; Antoch G; Wittsack HJ
Magn Reson Imaging; 2012 Dec; 30(10):1468-74. PubMed ID: 22819178
[TBL] [Abstract][Full Text] [Related]
28. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
29. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
30. Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen.
Dale BM; Braithwaite AC; Boll DT; Merkle EM
Invest Radiol; 2010 Feb; 45(2):104-8. PubMed ID: 20027117
[TBL] [Abstract][Full Text] [Related]
31. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
[TBL] [Abstract][Full Text] [Related]
32. [Diffusion weighted imaging: its diagnostic and differential value for prostate cancer].
Shi H; Ding HY
Zhonghua Nan Ke Xue; 2007 Jul; 13(7):605-9. PubMed ID: 17725302
[TBL] [Abstract][Full Text] [Related]
33. Diffusion tensor imaging of prostate at 3.0 Tesla.
Li C; Chen M; Li S; Zhao X; Zhang C; Liu M; Zhou C
Acta Radiol; 2011 Sep; 52(7):813-7. PubMed ID: 21586608
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
35. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
36. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance diffusion-weighted imaging: extraneurological applications.
Colagrande S; Carbone SF; Carusi LM; Cova M; Villari N
Radiol Med; 2006 Apr; 111(3):392-419. PubMed ID: 16683086
[TBL] [Abstract][Full Text] [Related]
38. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
[TBL] [Abstract][Full Text] [Related]
39. Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging?
Inada Y; Matsuki M; Nakai G; Tatsugami F; Tanikake M; Narabayashi I; Yamada T; Tsuji M
Eur J Radiol; 2009 Apr; 70(1):122-7. PubMed ID: 18182265
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
